'%20fill='none'%20fill-rule='evenodd'%3e%3cpath%20d='M7.497%2029.085s2.985.806%203.69-.538c1.658-3.153-3.086-13.225-3.086-13.225s5.502%2013.038%2011.82%2019.07c3.464%203.305%207.438%203.503%2010.166%201.999%205.572-3.077%2013.026-18.379%2013.854-19.916.829-1.539-5.422%2013.84-7.605%2017.3-2.183%203.462-4.066%207.458-11.143%207.69-8.462.275-17.696-12.38-17.696-12.38'%20fill='%230F9BD7'/%3e%3cg%20transform='translate(0%2016.123)'%3e%3cmask%20id='iz0ij2keyb'%20fill='%23fff'%3e%3cuse%20xlink:href='%23bbe95veu1a'/%3e%3c/mask%3e%3cpath%20d='M0%203.043C0%201.363%201.333%200%202.98%200c1.645%200%202.977%201.363%202.977%203.043%200%201.68-1.332%203.042-2.977%203.042C1.333%206.085%200%204.722%200%203.043'%20fill='%23ACD5F1'%20mask='url(%23iz0ij2keyb)'/%3e%3c/g%3e%3cg%20transform='translate(7.873)'%3e%3cmask%20id='vrpx36r1md'%20fill='%23fff'%3e%3cuse%20xlink:href='%23bwovqcdwic'/%3e%3c/mask%3e%3cpath%20d='M13.028%204.171s2.184-.77%202.484-.384c.63.804.528%201.614-1.206%203.614-1.73%201.999-6.7%207.304-6.7%207.304s10.186-9.316%2013.025-8.38c2.336.768%201.358%204.152.98%205.381-.377%201.231-4.97%2013.919-21.61%2040.292-.182.29%2024.462-29.757%2025.525-42.52.903-10.843-4.292-9.46-4.669-9.38-4.411.9-7.83%204.073-7.83%204.073'%20fill='%231A3967'%20mask='url(%23vrpx36r1md)'/%3e%3c/g%3e%3cpath%20d='M64.023%2029.175%2058.52%2015.877l-5.502%2013.298h11.005zm-5.964-17.374h.923L71.5%2041.356h-2.437l-4.243-10.209H52.22l-4.242%2010.21h-2.436L58.06%2011.8z'%20fill='%231A3967'/%3e%3cmask%20id='7uez1t42pf'%20fill='%23fff'%3e%3cuse%20xlink:href='%23z9efbhhede'/%3e%3c/mask%3e%3cpath%20fill='%231A3967'%20mask='url(%237uez1t42pf)'%20d='M75.616%2041.356h2.142V12.06h-2.142zM83.977%2022.011h2.1V25.1c1.806-2.275%203.948-3.433%206.551-3.433%204.285%200%206.722%202.832%206.722%207.893v11.798h-2.1V30.59c0-4.634-1.554-6.949-4.831-6.949-2.604%200-4.748%201.374-6.343%204.074v13.643h-2.1V22.01zM102.625%2022.011h2.352L111.7%2035.18l6.3-13.168h2.184L106.24%2051.095h-2.142l6.467-13.513zM123.46%2041.356h2.144V12.06h-2.145zM141.06%2031.404c-5.712.087-8.863%202.318-8.863%205.32%200%201.974%201.387%203.217%203.698%203.217%201.638%200%203.276-.857%205.166-2.487v-6.05zm-5.755%2010.38c-3.148%200-5.25-2.058-5.25-4.975%200-4.203%203.78-6.82%2011.006-7.12v-2.058c0-2.875-1.262-4.161-4.242-4.161-1.933%200-3.74.815-5.799%202.359v-2.103c2.06-1.415%203.992-2.144%205.965-2.144%204.454%200%206.177%202.06%206.177%206.562v10.124c0%20.856.21%201.245.672%201.245.587%200%201.133-.602%202.14-1.501v1.972c-1.216%201.159-2.266%201.76-3.066%201.76-1.218%200-1.723-.688-1.804-2.276-1.975%201.546-3.699%202.317-5.799%202.317zM149.335%2022.011h2.102V25.1c1.722-2.275%203.78-3.433%206.299-3.433%202.815%200%204.58%201.158%205.881%203.947%202.059-2.66%204.16-3.947%206.806-3.947%204.117%200%206.468%202.832%206.468%207.893v11.798h-2.142V30.59c0-4.634-1.47-6.949-4.579-6.949-2.478%200-4.537%201.374-6.006%204.074v13.643h-2.1V30.59c0-4.634-1.513-6.949-4.621-6.949-2.48%200-4.494%201.374-6.006%204.074v13.643h-2.102V22.01zM179.884%2019.427v1.083h.569c.602%200%20.86-.113.86-.558%200-.37-.285-.525-.86-.525h-.569zm1.826.539c0%20.403-.264.708-.687.757l.645%201.362h-.446l-.616-1.305h-.722v1.305h-.388v-2.928h1.034c.789%200%201.18.241%201.18.809zm.33-.916a2.192%202.192%200%200%200-1.587-.67c-.603%200-1.152.232-1.56.656a2.335%202.335%200%200%200-.666%201.622c0%20.603.236%201.169.66%201.603.421.433.975.672%201.566.672.582%200%201.152-.24%201.588-.679.417-.418.645-.97.645-1.596%200-.615-.228-1.182-.645-1.608zm.176-.177c.464.477.713%201.108.713%201.785%200%20.696-.249%201.305-.713%201.771a2.469%202.469%200%200%201-1.763.758c-.66%200-1.27-.266-1.74-.748a2.517%202.517%200%200%201-.73-1.78c0-.666.257-1.302.736-1.798a2.365%202.365%200%200%201%201.734-.73c.673%200%201.29.263%201.763.742z'/%3e%3c/g%3e%3c/svg%3e)
| Committees | Independence | |||
|---|---|---|---|---|
| Phillip A. SharpDirector | Science and Technology (Chair) | Independent | 21 yr | Not disclosed |
| Michael W. BonneyDirector | None | Not independent | 9 yr | Not disclosed |
2 seats
The board of the latest proxy statement.
Alnylam Pharmaceuticals: Board